Comparison of endometrial growth produced by unopposed conjugated estrogens or by micronized estradiol in postmenopausal women

This publication has 11 references indexed in Scilit:

• Transdermal hormonal replacement therapy with transdermal progestin every second month
  Maturitas, 1995
• Hormone replacement therapy and endometrial cancer risk: A meta-analysis
  Obstetrics & Gynecology, 1995
• Can progestin be limited to every third month only in postmenopausal women taking estrogen?
  Maturitas, 1995
• Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone
  American Journal of Obstetrics and Gynecology, 1994
• Postmenopausal unopposed estrogens characteristics of use in relation to the risk of endometrial carcinoma
  Annals of Epidemiology, 1993
• A new peroral estrogen/progestin combination for postmenopausal hormonal substitution: An open multicentric field study
  Maturitas, 1993
• Monitoring of oestrogen replacement therapy by vaginosonography of the endometrium
  Maturitas, 1992
• An Alternative Regimen of Hormone Replacement Therapy to Improve Patient Compliance
  Australian and New Zealand Journal of Obstetrics and Gynaecology, 1989
• Cigarette Smoking, Serum Estrogens, and Bone Loss during Hormone-Replacement Therapy Early after Menopause
  New England Journal of Medicine, 1985
• The Influence of Dietary Protein and Carbohydrate on the Principal Oxidative Biotransformations of Estradiol in Normal Subjects*
  Journal of Clinical Endocrinology & Metabolism, 1984